1. Home
  2. INVE vs SNTI Comparison

INVE vs SNTI Comparison

Compare INVE & SNTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INVE
  • SNTI
  • Stock Information
  • Founded
  • INVE 1990
  • SNTI 2016
  • Country
  • INVE United States
  • SNTI United States
  • Employees
  • INVE N/A
  • SNTI N/A
  • Industry
  • INVE Computer peripheral equipment
  • SNTI Biotechnology: Pharmaceutical Preparations
  • Sector
  • INVE Technology
  • SNTI Health Care
  • Exchange
  • INVE Nasdaq
  • SNTI Nasdaq
  • Market Cap
  • INVE 82.2M
  • SNTI 85.3M
  • IPO Year
  • INVE 1997
  • SNTI N/A
  • Fundamental
  • Price
  • INVE $3.16
  • SNTI $3.26
  • Analyst Decision
  • INVE Strong Buy
  • SNTI Strong Buy
  • Analyst Count
  • INVE 3
  • SNTI 1
  • Target Price
  • INVE $6.50
  • SNTI $12.00
  • AVG Volume (30 Days)
  • INVE 45.6K
  • SNTI 226.1K
  • Earning Date
  • INVE 05-07-2025
  • SNTI 05-06-2025
  • Dividend Yield
  • INVE N/A
  • SNTI N/A
  • EPS Growth
  • INVE N/A
  • SNTI N/A
  • EPS
  • INVE 3.12
  • SNTI N/A
  • Revenue
  • INVE $25,239,000.00
  • SNTI N/A
  • Revenue This Year
  • INVE N/A
  • SNTI N/A
  • Revenue Next Year
  • INVE $10.34
  • SNTI N/A
  • P/E Ratio
  • INVE $1.02
  • SNTI N/A
  • Revenue Growth
  • INVE N/A
  • SNTI N/A
  • 52 Week Low
  • INVE $2.86
  • SNTI $1.52
  • 52 Week High
  • INVE $5.15
  • SNTI $16.94
  • Technical
  • Relative Strength Index (RSI)
  • INVE 45.49
  • SNTI 44.18
  • Support Level
  • INVE $3.00
  • SNTI $3.10
  • Resistance Level
  • INVE $3.45
  • SNTI $3.47
  • Average True Range (ATR)
  • INVE 0.15
  • SNTI 0.42
  • MACD
  • INVE -0.01
  • SNTI -0.07
  • Stochastic Oscillator
  • INVE 35.56
  • SNTI 16.74

About INVE Identiv Inc.

Identiv Inc is a security technology company. It secures and manages access to physical places, things, and information. The company has two reportable segments namely the Premises segment which includes solutions to address the premises security market for government and enterprise, including access control, video surveillance, analytics, customer experience, and other applications. Its Identity segment includes products and solutions enabling secure access to information serving the logical access and cyber security market and protecting assets and objects in the IoT with RFID. Geographically, it generates maximum revenue from the Americas and also has a presence in Europe and the Middle East, and Asia-Pacific. The company derives the majority of revenue from the Identity segment.

About SNTI Senti Biosciences Inc.

Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.

Share on Social Networks: